PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity

The objective was to determine PON1 status as a predictor for organophosphorus insecticide sensitivity in a cohort of Latina mothers and newborns from the Salinas Valley, California, an area with high levels of organophosphorus insecticide use. PON1 status was established for 130 pregnant Latina women and their newborns using a high-throughput two substrate activity/analysis method which plots rates of diazoxon (DZO) hydrolysis against rates of paraoxon (PO) hydrolysis. Arylesterase activity (AREase) was determined using phenylacetate as a substrate, allowing comparison of PON1 levels across PON1192 genotypes in mothers and children. Phenylacetate hydrolysis is not affected by the Q192R polymorphism. Among newborns, levels of PON1 (AREase) varied by 26-fold (4.3–110.7 U/ml) and among mothers by 14-fold (19.8–281.4 U/ml). On average, children's PON1 levels were four-fold lower than the mothers' PON1 levels (P<0.001). Average PON1 levels in newborns were comparable with reported hPON1 levels in transgenic mice expressing human PON1Q192 or PON1R192, allowing for prediction of relative sensitivity to chlorpyrifos oxon (CPO) and DZO. The predicted range of variability in sensitivity of mothers and children in the same Latino cohort was 65-fold for DZO and 131 to 164-fold for CPO. Overall, these findings indicate that many of the newborns and some of the mothers in this cohort would be more susceptible to the adverse effects of specific organophosphorus pesticide exposure due to their PON1 status. Of particular concern are exposures of pregnant mothers and newborns with low PON1 status.

[1]  D. Barr,et al.  Organophosphate Urinary Metabolite Levels during Pregnancy and after Delivery in Women Living in an Agricultural Community , 2005, Environmental health perspectives.

[2]  R. Sunahara,et al.  Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M , 2005, Journal of Lipid Research.

[3]  M. Hinman,et al.  Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat. , 2005, Toxicology and applied pharmacology.

[4]  S. Wallenstein,et al.  Molecular haplotyping by linking emulsion PCR: analysis of paraoxonase 1 haplotypes and phenotypes , 2005, Nucleic acids research.

[5]  T. Slotkin,et al.  Developmental neurotoxicity of chlorpyrifos: targeting glial cells. , 2005, Environmental toxicology and pharmacology.

[6]  Jessica G. Young,et al.  Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. , 2005, Neurotoxicology.

[7]  M. Mackness,et al.  Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? , 2004, Free radical biology & medicine.

[8]  N. Jewell,et al.  Association of in Utero Organophosphate Pesticide Exposure and Fetal Growth and Length of Gestation in an Agricultural Population , 2004, Environmental health perspectives.

[9]  G. Jarvik,et al.  Determination of Paraoxonase 1 Status and Genotypes at Specific Polymorphic Sites , 2004, Current protocols in toxicology.

[10]  E. Birman-Deych,et al.  In utero pesticide exposure, maternal paraoxonase activity, and head circumference. , 2003, Environmental health perspectives.

[11]  R. Jackson,et al.  Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. , 2003, Environmental health perspectives.

[12]  D. Barr,et al.  Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. , 2003, Environmental health perspectives.

[13]  Asa Bradman,et al.  Cumulative organophosphate pesticide exposure and risk assessment among pregnant women living in an agricultural community: a case study from the CHAMACOS cohort. , 2003, Environmental health perspectives.

[14]  R. Pannbacker.  Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects , 2003 .

[15]  A. Tward,et al.  Expression of human paraoxonase (PON1) during development. , 2003, Pharmacogenetics.

[16]  S. Deakin,et al.  Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor. , 2003, The Biochemical journal.

[17]  Jia Chen,et al.  Increased influence of genetic variation on PON1 activity in neonates. , 2003, Environmental health perspectives.

[18]  C. Carlson,et al.  Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. , 2003, Pharmacogenetics.

[19]  F. Perera,et al.  Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. , 2002, Environmental health perspectives.

[20]  P. Landrigan,et al.  Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. , 2002, Environmental health perspectives.

[21]  N. Holland,et al.  CHAMACOS, A Longitudinal Birth Cohort Study: Lessons from the Fields , 2003 .

[22]  Richard A Fenske,et al.  Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State. , 2002, Environmental health perspectives.

[23]  P. Durrington,et al.  Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[24]  G. Jarvik,et al.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. , 2001, American journal of human genetics.

[25]  S. Deakin,et al.  Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. , 2001, Journal of lipid research.

[26]  A. Tward,et al.  Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. , 2000, Pharmacogenetics.

[27]  G. Schellenberg,et al.  Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Y. Ikeda,et al.  A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. , 2000, Atherosclerosis.

[29]  C. Pope,et al.  Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Sheets Lp.  A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides. , 2000 .

[31]  V. Moser,et al.  Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos. , 2000, Neurotoxicology.

[32]  L. Sheets.  A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides. , 2000, Neurotoxicology.

[33]  G. Schellenberg,et al.  Paraoxonase ( PON 1 ) Phenotype Is a Better Predictor of Vascular Disease Than Is PON 1 192 or PON 1 55 Genotype , 2000 .

[34]  C. Furlong,et al.  Determination of paraoxonase (PON1) status requires more than genotyping. , 1999, Pharmacogenetics.

[35]  R. Fenske,et al.  Farmworker exposure to organophosphorus pesticide residues during apple thinning in central Washington State. , 1999, American Industrial Hygiene Association journal.

[36]  B. La Du,et al.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[37]  B. Eskenazi,et al.  Exposures of children to organophosphate pesticides and their potential adverse health effects. , 1999, Environmental health perspectives.

[38]  V. Moser,et al.  Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[40]  V. Moser,et al.  Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. , 1998, Toxicology and applied pharmacology.

[41]  R. Fenske,et al.  Biological monitoring of organophosphorus pesticide exposure among children of agricultural workers in central Washington State. , 1997, Environmental health perspectives.

[42]  R. Fenske,et al.  Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring. , 1997, Journal of toxicology and environmental health.

[43]  C. Disteche,et al.  Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. , 1997, Pharmacogenetics (London).

[44]  J. Maurissen.  Organophosphate pesticides--neurological and respiratory toxicity. , 1997, Toxicology and industrial health.

[45]  M. Keifer,et al.  The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin , 1996, Nature Genetics.

[46]  R H Hill,et al.  Pesticide residues in urine of adults living in the United States: reference range concentrations. , 1995, Environmental research.

[47]  T. Satoh,et al.  Interindividual variation in carboxylesterase levels in human liver microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[48]  L. Costa,et al.  Paraoxonase protects against chlorpyrifos toxicity in mice. , 1995, Toxicology letters.

[49]  M. Abou‐Donia,et al.  In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase. , 1995, Neurotoxicology.

[50]  C. Abbott,et al.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. , 1994, The Biochemical journal.

[51]  L. Costa,et al.  Serum paraoxonase status: a major factor in determining resistance to organophosphates. , 1993, Journal of toxicology and environmental health.

[52]  D. Adler,et al.  Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. , 1993, Chemico-biological interactions.

[53]  S. Adkins,et al.  Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. , 1993, American journal of human genetics.

[54]  D. Adler,et al.  The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.

[55]  R. Humbert,et al.  Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. , 1991, Biochemistry.

[56]  C. Pope,et al.  Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. , 1991, Toxicology.

[57]  G. Omenn,et al.  Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats. , 1990, Toxicology and applied pharmacology.

[58]  A. Motulsky,et al.  Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. , 1989, Analytical biochemistry.

[59]  A. Motulsky,et al.  Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies. , 1983, American journal of human genetics.

[60]  E. Michielin,et al.  Characteristics and behaviour of arylesterase in human serum and liver , 1977, European journal of clinical investigation.

[61]  D. S. Stephens,et al.  Perinatal development of human blood esterases , 1973, Clinical pharmacology and therapeutics.

[62]  K. Augustinsson,et al.  AGE VARIATION IN PLASMA ARYLESTERASE ACTIVITY IN CHILDREN. , 1963, Clinica chimica acta; international journal of clinical chemistry.

[63]  A. Main.  The role of A-esterase in the acute toxicity of paraoxon, TEPP, and parathion. , 1956, Canadian journal of biochemistry and physiology.